ArticleBlood cancer journal2024

Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2

Mengshi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.